Clinical Trial Update: A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a once-daily dual HIV therapy combining etravirine with boosted darunavir/ritonavir in early treatment-experienced patients; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Ritonavir (Ritonavir)
• etravirine (etravirine)

Snippet

Sponsor: Tibotec, Inc | Conditions: Human Immunodeficiency Virus (HIV) | Phase 2 | Status: COMPLETED | Results posted: 2013-12-04